Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis

Fig. 2

Comparison of 5-Year All-Cause Mortality, Composite Incidence of Hepatic Decompensation, and Hepatocellular Carcinoma (HCC) between Cohorts; Kaplan Meier probabilities values are percent free of death (A), composite hepatic decompensation (B), and hepatocellular carcinoma (C). P values indicate P Log-rank Test. T2DM, Type 2 Diabetes; SGLT2-I, Sodium glucose cotransporter-2 inhibitors.; HR, Hazard Ratio; CI, Confidence Interval

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us